I. Introduction
The Jaundice is an important problem in the first week of life affecting approximately 60% of term and 80% of preterm infants (1) . Jaundice is attributable to physiological immaturity of neonates to handle increased bilirubin production. Basic pathophysiology of jaundice is same in term and preterm neonates, but premature babies are at a higher risk of developing hyperbilirubinemia. Phototherapy is the most widely used form of therapy for newborn infants with hyperbilirubenia in order to decrease the body burden of neurotoxic bilirubin (2, 3) . The commonly known side effects of phototherapy are loose stools, hyperthermia, dehydration fluid loss, skin burn, photoretinitis , low platelet count, increased red cell osmotic fragility, bronze baby syndrome, riboflavin deficiency and DNA damage and hypocalcemia. Neonatal hypocalcemia is defined as total serum calcium concentration of < 7 mg/dl or ionized calcium concentration of < 4mg/dl (<1 mol/L). Calcium is crucial for many biochemical processes, including blood coagulation, neuromuscular excitability, cell membrane integrity and function, and cellular enzymatic and secretory activity.
Hakinsons (6) and Hunter (5) hypothesized that phototherapy inhibits pineal secretion of melatonin which blocks the effect of cortisol on bone calcium . so cortisol increases bone uptake of calcium and induces hypocalcaemia. Kim (7) suggested decreased secretion of parathormone as the cause of hypocalcemia. In Hooman's study the urinary calcium excretion was significantly higher in phototherapy group. Romagnoli et al (1979) for the first time suggested the association of hypocalcemia with phototherapy in preterm newborns. Similarly Hakanson & Bergstrom (1981) 
II. Material and Methods
This was a prospective hospital based comparative study at Neonatal Intensive Care Unit (NICU) of Rajendra Institute Of Medical Sciences, Ranchi from June 2015 to may 2016 after taking ethical committee approval. The study group includes 60 neonates (40 terms and 20 preterm). All had hyperbilirubinemia. All the neonates included in the study group required phototherapy. The neonates in the control group having hyperbilirubinemia in physiological range and were managed without phototherapy. . Serum bilirubin & serum calcium were determined before & after 48 hour of phototherapy. Phototherapy was provided with four blue and two white lights placed at 30 cm from the neonates and delivering at least 20µ W/cm 2 /nm. A detailed antenatal, perinatal history and examination of neonates was done in all case of study and control group. Serum calcium was measured pre and post phototherapy of 48hrs, complete blood count, C reactive protein, S. bilirubin, blood groups of baby and mother was done as routine investigation in all cases. Total & direct bilirubin is measured by Diazo method, calcium by Arsenazo method. Blood group of newborn was analyzed by antisera method. Neonates were assessed for features of hypocalcemia i.e. seizures, apnea, jitteriness, increased extensor tone, clonus, hyperreflexia and stridors. Electrolytes were checked at 0 hour (first sample) and at 48 hours of phototherapy or at discontinuation of phototherapy (second sample) whichever is earlier. The first sample was considered as control.
III. Result
1. The Incidence of neonatal jaundice was 35% in this study. 2. Preterm neonates were 33% and 67% cases were term neonates in the present study.
3. The mean weight of cases in the preterm and term groups was 1.5 kg ± 0.5 and 2.7 kg± 0.2 respectively. 4. Majority of preterm babies (50%) developed jaundiced in day 2, while approximately 65% term babies developed it on day 3. 5. All the neonates responded to phototherapy and none of them required exchange transfusion 6. The mean serum bilirubin in jaundiced preterm babies showed a significant decline from 18.70 mg/dl ±1.65 to 11.85 mg/dl ±0.90 after phototherapy (p<0.005). 7. There was also a significant decline in mean serum bilirubin levels in terms babies from 15.45 mg/dl ± 3 to 10.15 mg/dl ±0.97 (p˂0.05). 8. 70% of preterm and 30 % of term neonates developed hypocalcemia. 9. The mean serum calcium levels in the preterm showed statistically significant fall from 8.41 mg/dl ± 0.466 to 7.1 mg/dl ± 0.793 (p˂0.05). A similar decline in the mean serum calcium level was seen in term babies (from 9.52 mg/dl ± 0.53 to 8.42 mg/dl ± 1.19) (p˂0.05). 10. Symptomatic hypocalcemia was seen in 35.7 % of preterm and 25 % of term babies. Jitteriness was the most common complications observed in both preterm (60%) and term (75%) neonates. Irritability was seen in 40% of preterm and 25% of term babies. Apnea and convulsion were not seen in any of the study groups. Table-1 : Calcium levels, pre-phototherapy and post-phototherapy in cases and controls. 
IV. Discussion
The incidence of neonatal hyperbilirubinemia among admitted newborns in NICU was 35% in the present study. Anand VR has reported the incidence of neonatal jaundice in total nursery admission as 54.6 %. In the present study, jaundice in preterm babies was observe in approximately 50% on day two,30% on day three and 15% on day four, while in term newborns, it was 25% on day two,65% on day three and 10% on day four. The mean serum calcium concentration in preterm (pre study) was similar in both case and control groups. The mean serum calcium level in case group was decreased significantly after giving phototherapy from 8.41 mg/dl±0.47 to 7.1 mg/dl±0.79 (p<0.05) while in control group (after 48 hours), it was from 9.66 mg/dl±0.45 to 9.6 mg/dl±0.64 (p=0.82). Difference has been analysed statistically by applying t-test and come out to be statistically significant (p<0.05). The mean serum calcium level in term (pre study) was similar in both cases and control groups. The mean serum calcium level in case group decreased after giving phototherapy from 9.52mg/dl±0.53 to 8.42mg/dl ±1.19 (p<0.05) and in control group (after 48 hours) it was from 9.64mg/dl±0.45 to 9.7mg/dl ±0.48 (p=0.88). Difference has been analysed statistically by applying t test and come out to be statistically significant (p<0.05). (10) 9.85± 1.23 9.09 ±0.93 <0.001 Karamifar et al (9) 9.53± 0.92 9.30± 1.11 0.043 Taheri et al (11) The incidence of symptomatic and asymptomatic hypocalcaemia induced by phototherapy is shown in table-10 in the present study. The hypocalcaemia was predominantly symptomatic in preterm newborns (35.7%) as compared to term newborns (25%). Karamifar H et al (2002) (9) observed hypocalcaemia in 14.4% of total icteric newborns. There were significant difference between the prevalence of hypocalcaemia in preterm (22.6%) and term neonates (8.7%) (p=0.018). Jitteriness was the most common symptom observed in symptomatic hypocalcaemia preterm (60%) and term (75%) babies. Out of 20 babies, 40% of preterm babies and 25% of term babies developed irritability. None of the preterm and term babies developed apnoea and convulsions.
V. Conclusion
Neonate requiring phototherapies for hyperbilirubinemia are at higher risk for development of hypocalcemia. This risk is even more in case of preterm babies. Therefore, timely monitoring of serum calcium levels and calcium supplementation is suggested.
